PESTEVAC VACCINE

Indications

• Measles
• Mumps
• Rubella
• Yellow fever
• Varicella (chickenpox)
• Rotavirus

Dosage

Children: Refer to specific vaccine guidelines for paediatric dosing.

Adults: Refer to specific vaccine guidelines for adult dosing.

Mechanism of action

Attenuated vaccines work by mimicking a natural infection. The weakened pathogen replicates in the body, stimulating the immune system to produce a response against it, which includes the activation of T-cells and the production of antibodies. This prepares the immune system to recognize and fight off the pathogen if exposed in the future.

Pharmacodynamics

The pharmacodynamics of attenuated vaccines involve the interaction of the attenuated pathogen with the host's immune system. Upon administration, the vaccine induces both humoral (antibody-mediated) and cell-mediated immunity. This leads to the development of memory cells that ensure a faster and more effective response upon subsequent exposure to the actual pathogen.

Pharmacokinetics

Attenuated vaccines are generally administered via subcutaneous or intramuscular injection. The pharmacokinetics are characterized by the distribution of the vaccine components within the body, with the attenuated organisms replicating locally and inducing an immune response. The onset of immunity typically occurs within weeks, and the duration of immunity can vary depending on the specific vaccine.

Contra-indications

• Severe immunodeficiency
• Pregnant women (specific live attenuated vaccines)
• Severe allergic reactions to vaccine components

Adverse effects

• Injection site reactions (pain, swelling, redness)
• Low-grade fever
• Malaise
• Rash
• Rare neurological complications (e.g., Guillain-Barré syndrome)

Interactions

• Immunosuppressive agents (may reduce vaccine efficacy)
• Blood products (may interfere with immune response to vaccine)
• Other live vaccines (timing may affect immune response)

Precautions

• History of allergic reactions to previous vaccinations
• Presence of active infections
• Chronic illnesses that may affect immune response

Pregnancy

Live attenuated vaccines are generally contraindicated during pregnancy due to potential risks to the fetus.

Breast-feeding

Most live attenuated vaccines are considered safe during breastfeeding, but caution and consultation with a healthcare provider are advised.

Storage

Store in a refrigerator at 2-8°C. Do not freeze. Protect from light.

Formulations

• Injectable suspension
• Oral suspension
• Lyophilized powder for reconstitution

Indications

• Blood transfusion
• Tissue transplantation
• Immunotherapy
• Vaccine administration

Dosage

Children: Refer to specific guidelines for the homologous product being used. Pediatric dosing will depend on the clinical need and product type.

Adults: Refer to specific guidelines for the homologous product being used. Dosage will vary based on clinical indications and the type of product administered.

Mechanism of action

Homologous products work by providing agents that are immunologically compatible with the recipient, thereby minimizing the risk of rejection and enhancing therapeutic efficacy. For example, homologous blood transfusions provide compatible blood cells that can improve oxygen delivery and volume status in patients.

Pharmacodynamics

The pharmacodynamics of homologous products depends on the specific application. In blood transfusions, homologous red blood cells increase the oxygen-carrying capacity of blood. In immunotherapy, homologous vaccines stimulate an immune response that is tailored to the individual's genetic makeup, promoting effective immunogenicity.

Pharmacokinetics

Pharmacokinetic properties of homologous products vary based on the specific substance. For blood components, the half-life is influenced by factors such as the volume transfused and the recipient's physiological status. Generally, homologous products are absorbed and distributed in a manner consistent with their biological functions, with elimination depending on the metabolic pathways of the components involved.

Pregnancy

Data on the use of homologous in pregnancy is limited. It is important to consider the potential benefits against the risks, and to consult available guidelines and clinical judgement.

Breast-feeding

Information on the excretion of homologous in human milk is not well-established. Caution is advised when used during breastfeeding.

Storage

Store at controlled room temperature, away from light and moisture. Specific storage conditions may vary depending on the formulation.

Indications

• Measles
• Mumps
• Rubella
• Varicella (chickenpox)
• Yellow fever
• Rotavirus
• Intranasal influenza

Dosage

Children: Refer to the BNF for Children for specific dosing information based on age and vaccine type.

Adults: Refer to specific product guidelines for dosing information, as it can vary by vaccine type and brand.

Mechanism of action

Live vaccines work by introducing a weakened or attenuated form of a pathogen into the body. This stimulates the immune system to recognize and respond to the pathogen, leading to the production of antibodies and memory cells that provide long-term protection against future infections by the same pathogen.

Pharmacodynamics

The pharmacodynamics of live vaccines involve the activation of both humoral and cellular immunity. Following vaccination, the immune system generates a robust response, including the production of specific antibodies and the activation of T cells that can recognize and eliminate infected cells. This dual action helps establish long-term immunity.

Pharmacokinetics

The pharmacokinetics of live vaccines vary depending on the specific vaccine. Generally, the vaccine is administered via injection, allowing the live attenuated organisms to enter the bloodstream. The immune response typically begins within days and can last for years, depending on the vaccine. Live vaccines are usually stored under refrigeration to maintain their viability, and they should be administered within their expiration dates.

Interactions

• livevaccines + abrocitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + baricitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + filgotinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + dexrazoxane: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + iron chelators: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ozanimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ponesimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + siponimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + upadacitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + diroximelfumarate: Moderate (increases risk of generalised infection (possibly life-threatening))

Indications

• Prevention of peste des petits ruminants in small ruminants
• Supportive care for infected sheep and goats

Dosage

Children: Refer to veterinary guidelines for specific dosing of vaccines and supportive treatments in young animals.

Adults: Refer to veterinary guidelines for specific dosing of vaccines and supportive treatments.

Mechanism of action

PPRV infects host cells by binding to the signaling lymphocyte activation molecule (SLAM) receptor on the surface of lymphocytes and other immune cells. This enables the virus to enter the cells and replicate, leading to cell death and impairment of the immune response. The resulting immune dysfunction contributes to the clinical manifestations of the disease.

Pharmacodynamics

The clinical signs of PPR are a result of the virus's impact on the immune system and respiratory tract. The disease leads to severe immunosuppression, making animals susceptible to secondary infections. Additionally, the destruction of epithelial cells in the respiratory and gastrointestinal tracts contributes to the symptoms observed during infection.

Pharmacokinetics

The pharmacokinetics of antiviral agents used in the management of PPR are not well defined due to the focus on vaccination and supportive care. Antiviral treatments, when used, would typically be administered based on the specific pharmacological properties of the agents chosen and the clinical condition of the affected animal.

Pregnancy

Limited data is available on the use of peste during pregnancy. Caution is advised.

Breast-feeding

Limited data is available on the excretion of peste in breast milk. Caution is advised.

Storage

Store in a cool, dry place, away from direct sunlight. Ensure that the product is tightly closed.

Indications

• Absence seizures
• Petit mal seizures
• Epilepsy management

Dosage

Children: Refer to BNF for Children for specific dosing recommendations based on the child's age, weight, and clinical condition.

Adults: Refer to clinical guidelines for specific dosing recommendations based on individual patient needs and response.

Mechanism of action

Petit acts primarily as a sodium channel blocker, modulating the excitability of neuronal membranes. It influences neurotransmitter release and inhibits the repetitive firing of action potentials, which is essential in controlling seizures. This mechanism helps to reduce the occurrence and severity of seizure episodes.

Pharmacodynamics

The pharmacodynamics of Petit involves the alteration of the neuronal excitability and the modulation of synaptic transmission. By stabilizing the neuronal membranes and reducing excitatory neurotransmitter activity, Petit effectively decreases the likelihood of seizure onset. Its efficacy is particularly noted in managing absence seizures, where the drug helps to restore normal electrical activity in the brain.

Pharmacokinetics

Petit is absorbed efficiently in the gastrointestinal tract, with peak plasma concentrations typically reached within a few hours post-administration. The drug has a moderate volume of distribution and is primarily metabolized in the liver, with metabolites excreted through the kidneys. The half-life of the drug can vary significantly based on individual patient factors and concurrent medications, necessitating close monitoring of plasma levels in clinical practice.

Pregnancy

Data on the safety of petit during pregnancy is limited. Consult a healthcare professional for advice.

Breast-feeding

The safety of petit during breastfeeding has not been established. Consult a healthcare professional before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Nutritional supplementation
• Treatment of gastrointestinal disorders
• Management of metabolic diseases
• Antimicrobial therapy for infections
• Control of parasitic infestations

Dosage

Children: Refer to specific veterinary guidelines for dosing in young ruminants, as it varies significantly by species and condition.

Adults: Dosage varies widely based on the specific medication, condition being treated, and the individual animal's health status. Refer to specific veterinary guidelines for appropriate dosing.

Mechanism of action

The mechanism of digestion in ruminants involves microbial fermentation in the rumen, where a complex community of microorganisms, including bacteria, protozoa, and fungi, breaks down cellulose and other polysaccharides into simpler compounds. This process produces volatile fatty acids, which serve as a primary energy source for the animal. Additionally, the ruminant's ability to regurgitate and re-chew food (cud) further aids in digestion and nutrient absorption.

Pharmacodynamics

The pharmacodynamics of ruminants is largely influenced by their diet and the microbial populations within their digestive system. Nutrient absorption occurs primarily in the small intestine, where amino acids, fatty acids, and glucose are taken up into the bloodstream. The efficiency of nutrient assimilation can be affected by dietary composition, health status, and the presence of various feed additives and medications.

Pharmacokinetics

Ruminants exhibit unique pharmacokinetic properties due to their specialized gastrointestinal tract. The absorption of drugs may be altered by the presence of food and the complex interactions within the rumen. Factors such as pH, microbial activity, and the rate of gastrointestinal transit can influence the bioavailability and efficacy of administered drugs. It is essential to consider these factors when prescribing medications for ruminants.

Pregnancy

Consult a veterinarian for specific guidance regarding the use of ruminants during pregnancy.

Breast-feeding

Consult a veterinarian for advice on the management of ruminants during lactation.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Dietary supplement for heart health
• Source of essential fatty acids
• Antioxidant support
• Promotion of digestive health
• Management of cholesterol levels

Dosage

Children: Refer to specific seed type and formulation for dosing information, as it can vary widely based on type and intended use.

Adults: Refer to specific seed type and formulation for dosing information, as it can vary widely based on type and intended use.

Mechanism of action

The bioactive compounds in seeds, such as polyunsaturated fatty acids, phytosterols, and antioxidants, exert various effects in the body. For example, omega-3 fatty acids found in flaxseeds can influence lipid metabolism and reduce inflammation by modulating the production of eicosanoids. Antioxidants such as tocopherols and phenolic compounds can scavenge free radicals, reducing oxidative stress.

Pharmacodynamics

Seeds have shown potential benefits, including the modulation of lipid profiles, reduction in inflammatory markers, and improvement in glycemic control. The consumption of seeds may lead to decreased low-density lipoprotein (LDL) cholesterol levels and increased high-density lipoprotein (HDL) cholesterol levels, contributing to cardiovascular health. The dietary fiber in seeds can also aid in digestive health and promote satiety.

Pharmacokinetics

The pharmacokinetics of seeds can vary widely depending on the type of seed and the specific compounds being analyzed. Generally, the bioactive components are digested and absorbed in the gastrointestinal tract, with fatty acids being incorporated into chylomicrons and transported via the lymphatic system. Antioxidants are absorbed in the small intestine and may have systemic effects, while fiber can influence gastrointestinal motility and fermentation in the colon.

Pregnancy

Consult a healthcare provider before use, as safety during pregnancy is not well established.

Breast-feeding

Consult a healthcare provider before use, as safety during breastfeeding is not well established.

Storage

Store in a cool, dry place, away from direct sunlight.

Indications

• Bacterial infections
• Viral infections
• Epidemiological studies
• Antibiotic resistance monitoring

Dosage

Children: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Adults: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Mechanism of action

The mechanism of action for a strain depends on the type of microorganism it represents. For pathogenic bacteria, the strain may produce toxins, evade the host's immune response, or possess resistance mechanisms that allow it to survive in the presence of antibiotics. For viruses, strains may exhibit mutations that alter their ability to infect host cells or evade antiviral therapies.

Pharmacodynamics

Pharmacodynamics in the context of strains involves the interaction between the strain and the host's immune system, as well as the effects of specific antimicrobial agents on the strain. These interactions can influence the efficacy of treatments and the development of resistance.

Pharmacokinetics

Pharmacokinetics is not directly applicable to strains themselves but rather to the drugs used to treat infections caused by specific strains. Factors such as absorption, distribution, metabolism, and excretion of antimicrobial agents can vary depending on the strain's characteristics and the site of infection.

Pregnancy

There is limited information on the safety of strain in pregnancy. It is advisable to consult healthcare professionals for guidance.

Breast-feeding

Safety during breastfeeding is not well established. It is recommended to seek medical advice before use.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Indications

• Influenza
• HIV/AIDS
• Hepatitis B and C
• Herpes simplex virus infections
• Cytomegalovirus infections
• COVID-19
• Respiratory syncytial virus infections

Dosage

Children: Refer to specific antiviral agents for dosing guidance.

Adults: Refer to specific antiviral agents for dosing guidance.

Mechanism of action

Viruses infect host cells by attaching to specific receptors on the cell surface. Once inside, they hijack the host cell's machinery to replicate their genetic material and produce viral proteins. New viral particles are assembled and released from the host cell, often destroying the cell in the process. The specific mechanism can vary depending on the virus type, including integration into the host genome in retroviruses or utilizing specific pathways for replication.

Pharmacodynamics

The pharmacodynamics of antiviral agents depend on the specific virus and the mechanism of action. Antiviral drugs may inhibit viral entry into host cells, block viral replication, or prevent the assembly of new virions. The effectiveness of antiviral therapy often relates to the stage of viral replication and the immune response of the host.

Pharmacokinetics

Pharmacokinetics of antiviral drugs varies widely based on the specific medication used. Generally, antiviral agents are absorbed through the gastrointestinal tract and distributed throughout the body. They may undergo hepatic metabolism and are often excreted through the kidneys. The half-life of these drugs can range from a few hours to several days, influencing dosing schedules.